Quidel Profit Margin 2006-2019 | QDEL

Current and historical gross margin, operating margin and net profit margin for Quidel (QDEL) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Quidel net profit margin as of March 31, 2019 is 12.98%.
Quidel Annual Profit Margins
Quidel Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.261B $0.522B
Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $151.296B 28.49
Medtronic (MDT) Ireland $135.350B 19.33
Stryker (SYK) United States $77.587B 27.69
Boston Scientific (BSX) United States $58.741B 28.16
Baxter (BAX) United States $42.165B 26.58
EssilorLuxottica Societe Anonyme (ESLOY) France $28.527B 0.00
Coloplast (CLPBY) Denmark $25.661B 40.97
Lonza Group Ag (LZAGY) Switzerland $25.304B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.194B 16.19
Terumo (TRUMY) Japan $22.193B 25.52
Smith & Nephew SNATS (SNN) United Kingdom $19.113B 0.00
ResMed (RMD) United States $17.749B 33.91
Canopy Growth (CGC) Canada $12.652B 0.00
Sunny Optical Technology (SNPTF) China $12.175B 0.00
Bio-Rad Laboratories (BIO) United States $9.194B 48.74
Aurora Cannabis (ACB) Canada $7.514B 74.10
William Demant Holdings (WILYY) Denmark $7.411B 0.00
Insulet (PODD) United States $7.236B 527.17
Hill-Rom Holdings (HRC) United States $7.121B 21.59
Perrigo (PRGO) Ireland $6.850B 11.58
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.254B 51.05
ICU Medical (ICUI) United States $5.122B 30.57
GW Pharmaceuticals (GWPH) United Kingdom $4.916B 0.00
Neogen (NEOG) United States $3.373B 54.85
NuVasive (NUVA) United States $2.987B 24.39
Hutchison China MediTech (HCM) China $2.906B 0.00
Agios Pharmaceuticals (AGIO) United States $2.848B 0.00
National Vision Holdings (EYE) United States $2.479B 52.82
Aphria (APHA) $1.646B 0.00
Cardiovascular Systems (CSII) United States $1.530B 878.80
Phibro Animal Health (PAHC) United States $1.212B 18.16
AtriCure (ATRC) United States $1.196B 0.00
VAREX IMAGING (VREX) United States $1.177B 24.98
NanoString Technologies (NSTG) United States $1.065B 0.00
Lantheus Holdings (LNTH) United States $1.052B 27.95
PetIQ (PETQ) United States $1.008B 24.49
Quanterix (QTRX) United States $0.783B 0.00
Cerus (CERS) United States $0.769B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.758B 21.26
Omeros (OMER) United States $0.758B 0.00
MacroGenics (MGNX) United States $0.740B 0.00
TG Therapeutics (TGTX) United States $0.686B 0.00
LeMaitre Vascular (LMAT) United States $0.591B 28.62
Surmodics (SRDX) United States $0.533B 77.45
OraSure Technologies (OSUR) United States $0.522B 24.06
Meridian Bioscience (VIVO) United States $0.489B 14.96
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.398B 0.00
Vapotherm (VAPO) United States $0.337B 0.00
Utah Medical Products (UTMD) United States $0.325B 22.51
BioLife Solutions (BLFS) United States $0.313B 97.88
Zynex (ZYXI) United States $0.242B 24.90
Cytosorbents (CTSO) United States $0.234B 0.00
Bovie Medical (APYX) United States $0.224B 0.00
Chimerix (CMRX) United States $0.184B 0.00
Owens & Minor (OMI) United States $0.178B 3.77
United Health Products (UEEC) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.168B 0.00
Female Health (VERU) United States $0.143B 0.00
Fonar (FONR) United States $0.141B 7.40
Chembio Diagnostics (CEMI) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.97
InfuSystems Holdings (INFU) United States $0.088B 0.00
Surface Oncology (SURF) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.057B 19.58
MRI INTERVENTNS (MRIC) United States $0.053B 0.00